| Item Type | Name |
|
Academic Article
|
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial.
|
|
Academic Article
|
Strontium-89 combined with doxorubicin in the treatment of patients with androgen-independent prostate cancer.
|
|
Concept
|
Doxorubicin
|
|
Academic Article
|
The impact of chemotherapy on the survival of patients with metastatic urothelial tumors.
|
|
Academic Article
|
Primary chemotherapy followed by a selective retroperitoneal lymphadenectomy in the management of clinical stage II testicular carcinoma: a preliminary report.
|
|
Academic Article
|
Sarcomatoid renal cell carcinoma. A treatable entity.
|
|
Academic Article
|
Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experience.
|
|
Academic Article
|
Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update.
|
|
Academic Article
|
Adjuvant chemotherapy of bladder cancer: a preliminary report.
|
|
Academic Article
|
Chemotherapy for adenocarcinomas of bladder and urachal origin: 5-fluorouracil, doxorubicin, and mitomycin-C.
|
|
Academic Article
|
Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer.
|
|
Academic Article
|
Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate.
|
|
Academic Article
|
A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.
|
|
Academic Article
|
Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
|
|
Academic Article
|
Cyclophosphamide, doxorubicin and cisplatin chemotherapy for patients with locally advanced urothelial tumors with or without nodal metastases.
|
|
Academic Article
|
Doxorubicin, mitomycin, and 5-FU (DMF) in the treatment of hormone-resistant stage D prostate cancer: a preliminary report.
|
|
Academic Article
|
Antiproliferative effects of cyclocreatine on human prostatic carcinoma cells.
|
|
Academic Article
|
Phase II trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer.
|
|
Academic Article
|
Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC.
|
|
Academic Article
|
A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial.
|
|
Academic Article
|
Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer.
|
|
Academic Article
|
Treatment of chemotherapy-refractory metastatic urothelial tumors.
|
|
Academic Article
|
Intensive chemotherapy for metastatic nonseminomatous germ cell tumors.
|
|
Academic Article
|
Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factor.
|
|
Academic Article
|
Have aggressive chemotherapy regimens improved results in advanced germ cell tumors.
|
|
Academic Article
|
Interferon alternating with chemotherapy for patients with metastatic renal cell carcinoma.
|
|
Academic Article
|
Endodermal sinus tumor of the mediastinum. Report of apparent cure in two patients with extensive disease.
|
|
Academic Article
|
Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer.
|
|
Academic Article
|
Chemotherapy of carcinoma of renal pelvis: preliminary report.
|
|
Academic Article
|
Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial.
|
|
Academic Article
|
Gemcitabine modulation of alkylator therapy: a phase I trial of escalating gemcitabine added to fixed doses of ifosfamide and doxorubicin.
|
|
Academic Article
|
Inhibition of in vivo proliferation of MDA-PCa-2b human prostate cancer by a targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207.
|
|
Academic Article
|
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
|
|
Academic Article
|
p21 modulates threshold of apoptosis induced by DNA-damage and growth factor withdrawal in prostate cancer cells.
|
|
Academic Article
|
Randomized, multicenter, phase II trial of two multicomponent regimens in androgen-independent prostate cancer.
|
|
Academic Article
|
Treatment of refractory urothelial carcinoma with alternating paclitaxel, methotrexate, cisplatin (TMP) and 5-fluorouracil, alpha-interferon, cisplatin (FAP).
|
|
Academic Article
|
Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy.
|
|
Academic Article
|
Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.
|
|
Academic Article
|
Cisplatin combination chemotherapy for elderly patients with urothelial tumours.
|
|
Academic Article
|
Cyclic chemotherapy with cyclophosphamide, doxorubicin, and cisplatin plus vinblastine and bleomycin in advanced germinal tumors. Results with 100 patients.
|
|
Academic Article
|
Chemotherapy of extragonadal germ cell tumors.
|
|
Academic Article
|
Complete responses in metastatic transitional cell carcinoma of the prostate with cisplatin regimens.
|
|
Academic Article
|
Management of pelvic complications of malignant urothelial tumors with combined intra-arterial and iv chemotherapy.
|
|
Academic Article
|
Phase I study of suramin combined with doxorubicin in the treatment of androgen-independent prostate cancer.
|
|
Academic Article
|
Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results.
|
|
Academic Article
|
Combined intravenous and intra-arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumors.
|
|
Academic Article
|
Perioperative chemotherapy for the management of primary local regional urothelial tumors.
|
|
Academic Article
|
Optimal delivery of perioperative chemotherapy: preliminary results of a randomized, prospective, comparative trial of preoperative and postoperative chemotherapy for invasive bladder carcinoma.
|
|
Academic Article
|
Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer.
|
|
Academic Article
|
Words of wisdom. Re: final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium.
|
|
Academic Article
|
Randomized phase 2 study of bone-targeted therapy containing strontium-89 in advanced castrate-sensitive prostate cancer.
|
|
Academic Article
|
Randomized phase 2 trial of ketoconazole and ketoconazole/doxorubicin in androgen independent prostate cancer
|
|
Academic Article
|
Sequential chemotherapy with cytoxan, adriamycin, and cis-platinum alternating with velban-bleomycin for stage III germinal cancer with poor prognosis
|
|
Academic Article
|
Doxorubicin, mitomycin-C, 5-fluorouracil (DMF) in the therapy of hormonal resistant adenocarcinoma of the prostate
|
|
Academic Article
|
Adriamycin programs and the sarcomatous variant of renal cell carcinoma
|
|
Academic Article
|
Randomized phase 2 trial of ketoconazole and ketoconazole/doxorubicin in androgen independent prostate cancer.
|